153 related articles for article (PubMed ID: 10746008)
1. [The impact of regulation of postprandial glucose in practice].
Vergès B
Diabetes Metab; 1999 Dec; 25 Suppl 7():22-5. PubMed ID: 10746008
[TBL] [Abstract][Full Text] [Related]
2. The impact of prandial glucose regulation in practice.
Vergès B
Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):28-32. PubMed ID: 12702005
[TBL] [Abstract][Full Text] [Related]
3. Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complications.
Hanefeld M; Temelkova-Kurktschiev T
Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):98-107. PubMed ID: 12189909
[TBL] [Abstract][Full Text] [Related]
4. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus.
Del Prato S; Tiengo A
Diabetes Metab Res Rev; 2001; 17(3):164-74. PubMed ID: 11424229
[TBL] [Abstract][Full Text] [Related]
5. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
6. [Is the regulation of prandial glucose important in type 2 diabetes?].
Home P
Diabetes Metab; 1999 Dec; 25 Suppl 7():20-1. PubMed ID: 10746007
[TBL] [Abstract][Full Text] [Related]
7. Early-phase prandial insulin secretion: its role in the pathogenesis of type 2 diabetes mellitus and its modulation by repaglinide.
Owens DR; Cozma LS; Luzio SD
Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):19-27. PubMed ID: 12702004
[TBL] [Abstract][Full Text] [Related]
8. Post-prandial hyperglycemia. post-prandial hyperglycemia and diabetes.
Gin H; Rigalleau V
Diabetes Metab; 2000 Sep; 26(4):265-72. PubMed ID: 11011218
[TBL] [Abstract][Full Text] [Related]
9. The importance of early insulin secretion and its impact on glycaemic regulation.
Garber AJ
Int J Obes Relat Metab Disord; 2000 Sep; 24 Suppl 3():S32-7. PubMed ID: 11063282
[TBL] [Abstract][Full Text] [Related]
10. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
[TBL] [Abstract][Full Text] [Related]
11. HNF1α defect influences post-prandial lipid regulation.
St-Jean M; Boudreau F; Carpentier AC; Hivert MF
PLoS One; 2017; 12(5):e0177110. PubMed ID: 28493909
[TBL] [Abstract][Full Text] [Related]
12. Exercise and Postprandial Glycemic Control in Type 2 Diabetes.
Kearney ML; Thyfault JP
Curr Diabetes Rev; 2016; 12(3):199-210. PubMed ID: 26073704
[TBL] [Abstract][Full Text] [Related]
13. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
Gallagher A; Home PD
Diabetes Res Clin Pract; 2005 Mar; 67(3):196-203. PubMed ID: 15713351
[TBL] [Abstract][Full Text] [Related]
14. Post-prandial glycemic control: molecular targets for pharmacological intervention.
Chandalia HB
J Assoc Physicians India; 2001 Jan; 49 Spec No():11-6. PubMed ID: 11235597
[No Abstract] [Full Text] [Related]
15. Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients.
Shiraiwa T; Kaneto H; Miyatsuka T; Kato K; Yamamoto K; Kawashima A; Kanda T; Suzuki M; Imano E; Matsuhisa M; Hori M; Yamasaki Y
Biochem Biophys Res Commun; 2005 Oct; 336(1):339-45. PubMed ID: 16140262
[TBL] [Abstract][Full Text] [Related]
16. Estimates of the relative and absolute diurnal contributions of fasting and post-prandial plasma glucose over a range of hyperglycaemia in type 2 diabetes.
Peter R; Dunseath G; Luzio SD; Owens DR
Diabetes Metab; 2013 Sep; 39(4):337-42. PubMed ID: 23993831
[TBL] [Abstract][Full Text] [Related]
17. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
[TBL] [Abstract][Full Text] [Related]
18. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
19. Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review.
Johansen OE; Birkeland KI
Am J Cardiovasc Drugs; 2007; 7(5):319-35. PubMed ID: 17953471
[TBL] [Abstract][Full Text] [Related]
20. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
